Cargando…
肺癌干性样细胞与耐药
Lung cancer remains the leading cause of cancer-related death world-wide. Therapy resistance and relapse are considered major reasons contributing to the poor survival rates of lung cancer. Accumulated evidences have demonstrated that a small subpopulation of stem-like cells existed within lung canc...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913289/ https://www.ncbi.nlm.nih.gov/pubmed/35224964 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.02 |
Ejemplares similares
-
MicroRNA与肺癌顺铂耐药相关性研究进展
Publicado: (2014) -
细胞周期检测点激酶与肺癌耐药研究进展
Publicado: (2021) -
肺癌低氧微环境与化疗耐药相关性研究进展
Publicado: (2014) -
非小细胞肺癌中microRNAs与EGFR-TKIs继发性耐药机制的研究进展
Publicado: (2014) -
侧群细胞与肺癌肿瘤干细胞
Publicado: (2012)